RepliCel Life Sciences Inc. (RepliCel), formerly Newcastle Resources Ltd. is a Canada-based company, engaged in the business of developing and patenting hair follicle cell replication technology. The Company’s cellular replication and implantation technology is designed to rejuvenate damaged, miniaturized hair follicles in balding scalp skin. The Company is developing an autologous cell-based procedure for the treatment of androgenetic alopecia (pattern baldness) and general hair loss in men and women. It is focused on ensuring the safety and demonstrating the efficacy of RepliCel’s cell-based hair regeneration procedure in humans. As of September 30, 2012, the Company‘s subsidiary included TrichoScience Innovations Inc. (TrichoScience).